Canada’s Drug Agency is pleased to announce the recipients of our 2024 Recognition Awards. These awards honour individuals who are pushing the science of health technology assessment (HTA) forward, mentoring the next generation of leaders, and helping to grow Canada’s reputation for excellence in the field.
This year marks the introduction of a new award that recognizes early-career professionals with the potential to become leaders in health economics. The award is named in honour of the late Dr. Murray Krahn, a beloved physician and giant in the field of economic evaluation and HTA.
Dr. Mina Tadrous is at the forefront of research that has led to meaningful change at both the policy and patient level. At the Ontario Drug Policy Research Network (ODPRN), he played a key role in implementing a novel framework for drug class reviews that enhanced standard HTA methods with patient and citizen perspectives and real-world evidence (RWE). This approach is driving formulary modernization in Ontario and elsewhere.
More News
Image
Jeffrey Henderson Receives Prestigious Connaught Innovation Award
Award will support research to advance novel method of modifying cells for testing new gene therapies.
Read More
Image
Faces of PharmSci: Mahya Rezaeifarimani
Supervised by Prof. Shirley Wu, PhD student Mahya Rezaeifarimani is developing smart nanoparticles to help make radiation therapy work better for brain tumours by targeting low-oxygen areas that often make treatment less effective.
Read More
Image
Welcome Brandi Cambray - Assistant Professor, Teaching Stream
Assistant Professor Cambray will continue educating students on clinical decision making, preparing them to practice to the fullest of their professional scope.
Read More